Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sharlene Day"'
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 3-3 (2024)
OBJECTIVES/GOALS: Study the regulatory role of sodium glucose co-transporter 1 (SGLT1) in cardiomyocytes and the therapeutic potential of sotagliflozin in hypertrophic cardiomyopathy (HCM) by (a) quantifying SGLT1 expression in HCM and (b) examining
Externí odkaz:
https://doaj.org/article/75a9baed77c84cfa9b32f9a3daa6094c
Autor:
Thomas L. Lynch, IVPhD, Diederik W.D. Kuster, PhD, Beverly Gonzalez, ScM, Neelam Balasubramanian, BA, Nandini Nair MD, PhD, Sharlene Day, PhD, Jenna E. Calvino, BA, Yanli Tan, RN, Christoph Liebetrau, MD, Christian Troidl, PhD, Christian W. Hamm, MD, Ahmet Güçlü, MD, Barbara McDonough, RN, Ali J. Marian, MD, Jolanda van der Velden, PhD, Christine E. Seidman, MD, Gordon S. Huggins, MD, Sakthivel Sadayappan, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 2, Pp 122-131 (2017)
Summary: The degradation and release of cardiac myosin binding protein-C (cMyBP-C) upon cardiac damage may stimulate an inflammatory response and autoantibody (AAb) production. We determined whether the presence of cMyBP-C-AAbs associated with advers
Externí odkaz:
https://doaj.org/article/29446172fbb5404fb9ce3f58703a24fc
Publikováno v:
European Journal of Preventive Cardiology. 30:488-495
HCM has long been considered the most frequent cause of death in athletes, and reason for disqualification from sport. However, our perception of the impact of sports on HCM is largely based on anecdotal evidence. In this review, we provide a reappra
Publikováno v:
Physiology. 38
Rationale: Hypertrophic Cardiomyopathy (HCM) is an inherited cardiovascular disease that affects 1 in 500 people. Over half of familial HCM cases arise from MyBP-C haploinsufficiency, thus stabilizing MyBP-C protein expression is an appealing therape
Publikováno v:
Physiology. 38
Background: Hypertrophic cardiomyopathy (HCM) is the most common genetically inherited cardiovascular disease that affects one in 500 people. Variants in MYBPC3 result in premature termination codons, ultimately causing haploinsufficiency in MyBP-C p
Autor:
Jonathan Herrera, Danielle Szczesniak, Kate Szczesniak, Rose‐Carmel Goddard, Jaime Yob, Sharlene Day
Publikováno v:
The FASEB Journal. 36
Autor:
Eric Smith, Brynn Elder, Gabriela Chen, Yao-chang Tsan, John Stendahl, Jodie Ingles, Victoria N Parikh, Samuel Wittekind, Steven Colan, Neal K Lakdawala, Anjali T Owens, Daniel L Jacoby, Sharlene Day, Christopher Semsarian, iacopo olivotto, Carolyn Ho, Mark W Russell, Sara Saberi, James S Ware, Adam S Helms
Publikováno v:
Circulation. 144
Introduction: Genetic hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited condition primarily due to pathogenic variants in sarcomere genes, often with marked clinical variability. We hypothesized that this variability may, in part,
Autor:
Thomas M Roston, iacopo olivotto, Sharlene Day, Victoria N Parikh, Michelle Michels, Jodie Ingles, Christopher Semsarian, Daniel L Jacoby, Steven D Colan, Joseph Rossano, Samuel Wittekind, James S Ware, Lin Zhang, Sara Saberi, Adam S Helms, Carolyn Ho
Publikováno v:
Circulation. 144
Introduction: Pressure overload from hypertension (HTN) is an important cause of left ventricular hypertrophy (LVH) in the general population, however its impact on disease expression in hypertrophic cardiomyopathy (HCM), and differences based on the
Autor:
Rachel Lampert, Michael J Ackerman, Bradley S Marino, Matthew Burg, Barbara Ainsworth, Lisa Salberg, Maite Tome, Seshadri Balaji, Carolyn Ho, Richard J Czosek, Cynthia James, Michael Emery, Robert Cooper, Martijn Bos, Jeffrey B Geske, Lubna Choudhury, Susan P Etheridge, Ashwin K Lal, James S Ware, Anne M Dubin, Belinda Gray, Silvana M Molossi, Martin S Maron, Sara Saberi, Daniel L Jacoby, Benjamin W Eidem, Kimberly Harmon, Kevin Hall, Brian Olshansky, Mark S Link, Ian Law, Elizabeth V Saarel, N A Estes, Barry Maron, David S Cannom, Fangyong Li, Kaylie Briske, Laura Simone, Cheryl Barth, Maryann Concannon, Sharlene Day
Publikováno v:
Circulation. 144
Introduction: Safety of vigorous exercise for individuals with appropriately-treated HCM remains debated. Physical activity practices in this population have not been described. The objective of this report is to describe physical activity pattern in
Autor:
Michael Levin, Noah Tsao, Tiffany Bellomo, William P Bone, Renae Judy, Megan Burke, Michael Morley, Yifan Yang, Sharlene Day, Zoltan Arany, Patrick T Ellinor, Thomas P Cappola, Kenneth B Margulies, Benjamin F Voight, Scott Damrauer
Publikováno v:
Circulation. 144
Introduction: The contribution of common genetic variation to heart failure (HF) risk has not been fully elucidated. Here, we applied multi-ancestry and multivariate methods to summary genetic data from >1 million individuals to improve power to iden